Roche

GlaxoSmithKline's 4.8% Yield Makes It Attractive With Or Without Human Genome Takeover
Seeking Alpha
Tue, 05/15/12 - 10:40 am
GSK
Human Genome Sciences
Novartis
Pfizer
Roche
Cancer Tools Help Roche Push Ahead With Alzheimer’s Drug
Bloomberg
Mon, 05/14/12 - 10:17 am
Roche
Alzheimer's disease
bapineuzumab
Bright Future Ahead Of Abbott Despite Mounting Competition
Seeking Alpha
Tue, 05/8/12 - 07:17 pm
Abbott Laboratories
Merck
Nestle
Pfizer
Roche
Sanofi
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
Roche Drops After Halting Cholesterol Drug Development
Bloomberg
Mon, 05/7/12 - 10:58 am
Roche
dalcetrapib
Diving for Dividend Growth in Big Pharma
Motley Fool
Fri, 05/4/12 - 10:40 am
dividends
GSK
Novartis
AstraZeneca
Sanofi
Abbott Laboratories
Roche
Bayer
Avastin, Lucentis equally effective at improving vision, big study finds
Fierce Pharma
Tue, 05/1/12 - 12:39 pm
Lucentis
Avastin
Roche
Novartis
macular degeneration
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Mon, 04/30/12 - 10:13 am
Eli Lilly
Merck
Northwest Biotherapeutics
Roche
brain cancer
Temodar
Erbitux
DCVax
Avastin
Drug Companies in M&A Rush
WSJ Online
Wed, 04/25/12 - 10:24 am
M&A
Watson Pharmaceuticals
Actavis
Ardea
AstraZeneca
Roche
Illumina
GSK
Human Genome Sciences
Illumina And Human Genome: Reasons For Rejections Of Takeovers
Seeking Alpha
Mon, 04/23/12 - 12:15 pm
M&A
Illumina
Roche
Human Genome Sciences
GSK
Galena Biopharma: How Long Can Big Pharma Wait?
Seeking Alpha
Mon, 04/23/12 - 11:10 am
Galena Biopharma
Roche
NeuVax
breast cancer
Roche talks to Illumina rivals after drops bid: paper
Yahoo/Reuters
Sun, 04/22/12 - 12:06 pm
Roche
Illumina
M&A
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
GS-7977
Vertex Pharmaceuticals
hepatitis C
Roche
Bristol-Myers Squibb
Merck
Gilead Sciences
JNJ
This Takeover Is Off the Table. Maybe.
Motley Fool
Fri, 04/20/12 - 10:35 am
M&A
Roche
Illumina
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Roche not to extend tender offer for Illumina
Markewatch
Wed, 04/18/12 - 10:02 am
Roche
M&A
Illumina
Illumina Win in Board Contest May Signal Long Roche Fight
Bloomberg
Tue, 04/17/12 - 10:29 am
Roche
M&A
Illumina
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sun, 04/15/12 - 12:23 pm
Erivedge
Curis
Roche
basal cell carcinoma
Roche Sales Slip, But Hints at Willingness to Lift Illumina Offer
FOX Business
Thu, 04/12/12 - 11:32 am
Roche
Illumina
earnings
M&A
Roche Willing to Consider Added ‘Value’ in Illumina Bid
Bloomberg
Sat, 04/7/12 - 11:52 am
Roche
Illumina
M&A

Pages